Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: Long-acting anti-inflammatory injectable DEX-Gel with sustained release and self-healing properties regulates TH1/TH2 immune balance for minimally invasive treatment of allergic rhinitis

Fig. 6

DEX-Gel regulates the inflammatory cytokines and the balance of THI/TH2 cell subsets. A–F Representative flow charts and changes in the numbers of IL4, IL5, IL17, IFN-γ, CD4+ IFN-γ+ TH1, and CD4+ IL4+ TH2 cell subsets in the nasal mucosa (n = 3). G–I The ratio of IFN-γ/IL4, IFN-γ/IL5, and TH1/TH2 cell subsets in the nasal mucosa (n = 3). Data are expressed as mean ± SD. *P < 0.05, **P < 0.01 and ***P < 0.001, significantly different from the ANOVA group

Back to article page